MorphImmune

West Lafayette, United States

MorphImmune is a preclinical biotechnology company that targets small-molecule therapeutics.

$15.0M raised

May 2023

Venture - Series Unknown

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about MorphImmune

How much funding has MorphImmune raised?

MorphImmune has raised $15.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2023.

Where is MorphImmune headquartered?

MorphImmune is headquartered in West Lafayette, United States.

What does MorphImmune do?

MorphImmune is a preclinical biotechnology company that targets small-molecule therapeutics.

What stage is MorphImmune at?

MorphImmune is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 16, 2023.

MLA

"MorphImmune — Funding & Investors." VCBacked, May 16, 2023, https://www.vcbacked.co/company/morphimmune. Accessed July 2, 2026.

APA

VCBacked. (2023). MorphImmune — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/morphimmune

Wikipedia (cite web)

{{cite web |title=MorphImmune — Funding & Investors |url=https://www.vcbacked.co/company/morphimmune |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 16, 2023.